STAT

APRIL 12, 2024

The recent detection of H5N1 bird flu in U.S. cattle, coupled with reports of a dairy worker contracting the virus , demands a departure from the usual reassurances offered by federal health officials. While they emphasize there’s no cause for alarm and assert diligent monitoring, it’s imperative we break from this familiar script. H5N1, a strain of the flu virus known to infect bird species globally and several mammalian species in the U.S. since 2022, has now appeared to have bre

364

364

PharmaVoice

APRIL 8, 2024

The market is huge, but will companies overcome the triple hurdles of payer hesitance, prescriber reluctance and sluggish consumer demand?

306

306

ALiEM - Pharm Pearls

APRIL 12, 2024

Traditionally large-bore tube thoracostomy has been the standard of care for treating many acute intrathoracic pathologies [1]. However, the advent of less invasive small-bore chest tubes, also known as pigtail catheters, has gradually led to a paradigm shift. Pigtails provide a less invasive and often better tolerated alternative to traditional chest tubes and allow for adequate treatment of pneumothoraces and uncomplicated pleural effusions [1-5].

Inpatient 183

Inpatient 183

BioPharma Dive

APRIL 8, 2024

Recent biotech company acquisitions have put emerging schizophrenia treatments in focus. But many development hurdles still stand in the way of new medicines for the brain.

137

137

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

APRIL 11, 2024

WASHINGTON — Bernie Sanders is pushing for a long Covid “moonshot.” He released a draft legislative proposal this week, a follow up to a milestone hearing in January that sounded the alarm on long Covid as a pressing public health crisis. The pitch calls for $10 billion in mandatory funding over the next decade to establish a new long Covid research program at the National Institutes of Health.

363

363

PharmaVoice

APRIL 8, 2024

GenAI is profoundly reshaping various facets of the pharmaceutical industry. Projections indicate that the global GenAI market in pharma will soar to USD 2258.1 million by 2032.

264

264

BioPharma Dive

APRIL 10, 2024

The first medicine approved for PPD, Sage’s Zulresso, never gained traction. The company is in the midst of launching its second, but long-standing challenges could slow uptake.

130

130

STAT

APRIL 8, 2024

Anyone can now walk into a pharmacy in the United States and buy oral contraceptives over the counter without a prescription, thanks to the FDA’s approval of norgestrel (Opill). This change reflects the drug’s safety and the public health imperative to ensure wider access to birth control. But another safe class of medicine that addresses a massive public health need remains unavailable except by prescription: the antidepressants known as selective serotonin reuptake inhibitor

364

364

PharmaVoice

APRIL 8, 2024

Underrepresentation of women in clinical trials affects the resulting drugs that are available down the line. Encouraging more women to partake is a critical step in promoting more equitable healthcare.

264

264

The Pharmacist

APRIL 12, 2024

The number of phone calls to pharmacies more than tripled between February and March 2020, while home deliveries of medication to vulnerable patients more than doubled, the UK Covid-19 Inquiry heard this week. Speaking on behalf of the National Pharmacy Association (NPA) at the inquiry hearing this week, legal representative Deirdre Domingo, said members had […] The post Calls to pharmacies tripled during pandemic, inquiry told appeared first on The Pharmacist.

120

120

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

PharmaTech

APRIL 12, 2024

The agency’s risk assessment committee has concluded that available evidence has not been found that supports a causal association between glucagon-like peptide-1 receptor agonists and self-harming thoughts and actions.

Diabetes 119

Diabetes 119

STAT

APRIL 7, 2024

SAN DIEGO — Cancer cases among younger people have been rising for years, a trend researchers have struggled to explain. New evidence suggests a significant factor: younger generations seem to be aging faster at the cellular level than their predecessors. A team of scientists at Washington University in St. Louis tracked data from nearly 150,000 people between the ages of 37 and 54 in the U.K.

363

363

PharmaVoice

APRIL 10, 2024

Recent biotech company acquisitions have put emerging schizophrenia treatments in focus. But many development hurdles still stand in the way of new medicines for the brain.

240

240

The Pharmacist

APRIL 8, 2024

A rise in measles cases in London has brought the capital in line with the number of cases recorded in the West Midlands – the initial hotspot for the virus. This comes as the rise in cases appears to be plateauing across the country and as a national catch-up campaign has increased vaccination uptake over […] The post Measles cases in London now in line with West Midlands appeared first on The Pharmacist.

Vaccines 121

Vaccines 121

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharma Times

APRIL 12, 2024

NSCLC is the most common type of lung cancer and is responsible for up to 85% of all cases

157

157

STAT

APRIL 8, 2024

For the vast majority of pancreatic cancer cases, the tumor grows undetected until it has already spread locally or to distant parts of the body. That means most patients, over 80% by some estimates, are diagnosed when it’s already too late to do surgery — depriving them of their best chance for a cure. “For the majority of patients, we cannot resect the tumor.

363

363

PharmaVoice

APRIL 10, 2024

TAE Life Sciences is bringing radiation-based cancer therapy to clinical trials globally in the coming years.

298

298

BioPharma Dive

APRIL 10, 2024

The company said the pause is necessary to meet regulatory limits on nitrosamine, but added it will not affect commercial supply nor regulatory review of the drug in early breast cancer.

119

119

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmaTech

APRIL 11, 2024

The draft guidance provides recommendations for data integrity for clinical and bioanalytical portions of bioavailability and bioequivalence studies submitted with drug applications.

116

116

STAT

APRIL 11, 2024

Medicare for the first time has estimated that a new Alzheimer’s treatment could cost the program billions of dollars by next year — well beyond what Wall Street or even the drug’s manufacturer have projected — according to a document obtained by STAT. Medicare’s actuaries expect the drug Leqembi , made by the Japanese drugmaker Eisai and sold in partnership with Biogen, to cost the traditional Medicare program around $550 million in 2024, and the entire Medica

Documentation 363

Documentation 363

PharmaVoice

APRIL 12, 2024

Why these clinical setbacks impacted the companies, industry and patients.

246

246

BioPharma Dive

APRIL 10, 2024

The deal, which company CEO Reshma Kewalramani described as “just the right fit,” is the largest acquistion in Vertex’s 35-year history.

126

126

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

The Pharmacist

APRIL 9, 2024

A new training programme to support the Pharmacy Independent Prescribing Service (PIPS) in Wales has been announced by the Royal Pharmaceutical Society (RPS) and Health Education and Improvement Wales (HEIW). Written by practicing pharmacist prescribers and general practitioners, the training content will explore conditions that pharmacists practicing as prescribers in the community might be likely […] The post RPS and HEIW partner for prescribing training in Wales appeared first on The Ph

112

112

STAT

APRIL 10, 2024

SAN DIEGO — Cancer vaccines have traveled a potholed road over the last decade. But as researchers from different companies and academic institutions presented promising early data at the American Association for Cancer Research annual meeting in San Diego this week, experts said there’s a collective feeling of turning a corner. “There’s a lot more interest in vaccines” now that the technology is improving, said Roy Herbst, chief of medical oncology at Yale Can

Vaccines 364

Vaccines Immunity Immunization Drug Development 364

PharmaVoice

APRIL 9, 2024

More than 20% of Americans are forgoing prescription medications due to costs, but the industry continues to fight policy measures.

Drug Pricing 162

Drug Pricing 162

pharmaphorum

APRIL 10, 2024

Discover how Sunshine transparency reporting can be simplified, streamlined, and secured for emerging pharmaceutical companies with a focus on Healthcare Professionals (HCP) and Healthcare Organisations (HCO).

Pharmaceutical Companies 119

Pharmaceutical Companies Pharmaceutical Companies 119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

The Pharmacist

APRIL 11, 2024

The Primary Care Pharmacy Association (PCPA) has joined other healthcare organisations in calling for the safeguarding of healthcare facilities and personnel in areas of conflict. Dr Graham Stretch, PCPA president, told The Pharmacist that he signed the open letter, coordinated by the World Health Professions Alliance, last week following a short discussion with the PCPA executive committee. […] The post PCPA joins calls for healthcare protection in conflict areas appeared first on The Pha

109

109

STAT

APRIL 9, 2024

One of the country’s biggest life insurers is venturing into genetic testing, an area that’s historically been a minefield for that industry, in a purported effort to keep its members alive longer.  MassMutual announced Tuesday that it’s offering many of its 4.2 million policyholders free genetic risk assessments for eight common diseases, like heart disease, type 2 diabetes, and breast cancer.

Diabetes 363

Diabetes 363

Pharma Times

APRIL 11, 2024

RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR

151

151

pharmaphorum

APRIL 9, 2024

Great Ormond Street Hospital is applying for the license to a gene therapy for rare disease ADA-SCID that was abandoned by a biotech developer on commercial grounds.

Hospitals 119

Hospitals 119

The Pharmacist

APRIL 10, 2024

Government and regulators must ‘clearly communicate’ the extent of community pharmacists’ responsibilities when asked to dispense privately prescribed puberty suppressing hormones to children and young people, an independent review has said. The final report of the Cass review, published today, called for measures to reduce inappropriate overseas prescribing of puberty suppressing hormones.

Communication 107

Communication 107